Test Price
2,800 AED✅ Home Collection Available
MAGT1 Gene Mental Retardation, X‑Linked Type 95 (XLMR‑95) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Precision: 99.9% sensitivity via ISO‑accredited Next‑Generation Sequencing (NGS) with full ACMG variant classification for confident molecular diagnosis of X‑linked mental retardation type 95.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM; dedicated medical courier for solid tissue specimens where applicable.
Clinical Guidance: Complimentary pre‑ and post‑test tele‑counselling by a DHA‑licensed Consultant Medical Geneticist to ensure result interpretation and personalised care planning.
Insurance Verification: Direct billing confirmation via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This state‑of‑the‑art Next‑Generation Sequencing (NGS) test analyses the MAGT1 gene for pathogenic variants linked to X‑linked mental retardation type 95, providing a definitive molecular diagnosis for neurodevelopmental delay. High‑depth sequencing on the Illumina platform with bioinformatic filtering and ACMG guidelines ensures >99.9% sensitivity for single‑nucleotide variants, small insertions/deletions, and copy‑number changes. The test is intended for individuals with suspected X‑linked intellectual disability, developmental regression, or a family history consistent with XLMR‑95.
| Feature | Our MAGT1 NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Diagnostic Precision | >99.9% sensitivity for single‑nucleotide variants, small indels, and copy‑number changes | ~95% sensitivity; limited to targeted coding regions, may miss large deletions |
| Methodology | High‑depth Next‑Generation Sequencing (Illumina platform) with bioinformatic filtering and ACMG variant classification | Capillary electrophoresis‑based Sanger chemistry; lower throughput |
| Turnaround Time | 3–4 weeks (expedited reporting available upon request) | 4–6 weeks |
| Clinical Support | Included: pre‑test genetic counselling, detailed variant report, post‑test tele‑counselling by a Consultant Medical Geneticist | Report only; often requires separate referral to a genetic specialist |
Physician Insight & Safety Protocols
“A molecular diagnosis of X‑linked mental retardation type 95 can transform a family’s journey from uncertainty to targeted management. The MAGT1 gene test is a powerful tool, but its greatest value emerges when results are integrated with developmental assessments, family history, and multidisciplinary care. I advise families to view this test as a gateway to informed support — not an endpoint — and to remain closely connected with their neurologist and genetic counsellor throughout the process.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Prescription & Management Advisory
Continue all prescribed therapies — including antiepileptics, psychotropics, and developmental interventions — unless your treating physician explicitly advises otherwise. This genetic test provides diagnostic clarification and does not replace ongoing clinical monitoring or medication management.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for acute neurological emergencies or as the sole diagnostic tool for sudden‑onset encephalopathy.
- Immediate emergency care is required for: new‑onset seizures, loss of consciousness, acute visual or motor regression, or signs of raised intracranial pressure.
- Individuals with active bleeding disorders or severe needle phobia may need specialised collection arrangements — contact our clinical team before scheduling.
Patient FAQ & Clinical Guidance
1. What is the purpose of the MAGT1 Genetic Test?
This test identifies pathogenic variants in the MAGT1 gene to confirm a diagnosis of X‑linked mental retardation type 95. The result guides clinical management, family counselling, and early intervention strategies for neurodevelopmental delay.
2. How is the sample collected, and is it painful?
A certified phlebotomist collects a peripheral whole blood sample or a dried blood spot card — a quick, minimally discomforting procedure that yields high‑quality DNA for NGS analysis. Our VIP Mobile Phlebotomy service brings this convenience to your home between 8 AM and 11 PM daily.
3. How long until I receive the results, and what does the report include?
Results are delivered within 3–4 weeks. Your comprehensive report details variant classification using ACMG criteria, clinical significance, inheritance pattern, and a dedicated post‑test tele‑counselling session with a Consultant Medical Geneticist to discuss next steps.
4. Who should consider this test?
This test is recommended for individuals with unexplained intellectual disability, developmental delay, autism spectrum features, or a family history of X‑linked neurodevelopmental disorders. It is also valuable for carrier testing in at‑risk female relatives.
5. Does insurance cover the cost of the test?
We offer direct billing verification with most UAE insurers. Send your policy details via WhatsApp at +971 54 548 8731 to confirm coverage before booking. Self‑pay options are also available at the listed price.
UAE Regulatory & Data Privacy Adherence
Data Protection & Confidentiality: All genetic data is processed in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic information is encrypted, access‑controlled, and used solely for diagnostic interpretation and clinically authorised purposes.
Clinical Safety & Consent: Patient safety and informed consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Every test is performed under the supervision of DHA‑licensed medical professionals in an accredited laboratory facility.
Laboratory Accreditation: DNA Labs UAE holds all required DHA and international quality certifications to ensure the highest standards of molecular genetic testing and reporting integrity.
Clinical & Logistical Metadata
| Test Name | MAGT1 Gene Mental Retardation, X‑Linked Type 95 (XLMR‑95) Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Dried Blood Spot (DBS) Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina Platform with ACMG Variant Classification |
| ICD-10-CM Code | F78.8 (Other intellectual disabilities) |
| LOINC Code | 94244-2 (MAGT1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians